Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Reassessing lidocaine as an electroporation sensitizer in vitro
ID
Blažič, Anja
(
Author
),
ID
Šmerc, Rok
(
Author
),
ID
Polajžer, Tamara
(
Author
),
ID
Miklavčič, Damijan
(
Author
)
PDF - Presentation file,
Download
(7,07 MB)
MD5: D744E32A8D8776AD6CEB930F8067A26C
URL - Source URL, Visit
https://www.nature.com/articles/s41598-025-11695-3
Image galllery
Abstract
High-intensity pulsed electric fields induce transient increase in membrane permeability, a phenomenon known as electroporation, with broad applications in medicine, including electrochemotherapy (ECT), gene electrotransfer and tissue ablation. As electroporation technologies become increasingly established in clinical practice, understanding how commonly used pharmacological agents influence treatment outcomes is gaining importance. Lidocaine, a widely used local anesthetic and ion channel modulator, has recently been investigated as a potential sensitizer to enhance the efficacy of electroporation. Here, we examined the effects of lidocaine on membrane permeabilization and cell viability using standard 8 × 100 µs ECT pulses across four cell lines: melanoma B16-F1, myoblast C2C12, CHO-K1 cells with low ion channel expression, and NS-HEK cells with stable ▫$Na_v$▫1.5 expression. We show that 10 mM lidocaine has only modest effects on electroporation outcomes, while 35 mM considerably lowers the electric field threshold for irreversible electroporation by 25–40% in melanoma cells. However, concentrations of even 10 mM exceed those reported in tissues following local administration of lidocaine. This questions the clinical relevance of lidocaine’s sensitization effect and warrants further investigation. Our study also highlights the importance of evaluating drug–electroporation interactions under rigorously controlled experimental conditions to ensure meaningful translation into clinical applications.
Language:
English
Keywords:
electroporation
,
sensitization
,
electropermeabilization
,
cell survival
,
lidocaione
,
melanoma cells
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FE - Faculty of Electrical Engineering
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
15 str.
Numbering:
15, art. 25593
PID:
20.500.12556/RUL-170893
UDC:
602.621
ISSN on article:
2045-2322
DOI:
10.1038/s41598-025-11695-3
COBISS.SI-ID:
243181571
Publication date in RUL:
21.07.2025
Views:
201
Downloads:
52
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Scientific reports
Shortened title:
Sci. rep.
Publisher:
Nature Publishing Group
ISSN:
2045-2322
COBISS.SI-ID:
18727432
Secondary language
Language:
Slovenian
Keywords:
elektroporacija
,
senzitizacija
,
preživetje celic
,
lidokain
,
celice melanoma
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P2-0249
Name:
Elektroporacija v biologiji, biotehnologiji in medicini
Funder:
ARIS - Slovenian Research and Innovation Agency
Funding programme:
Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)
Project number:
I0-0022
Name:
Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J2-2503
Name:
Vpliv visokonapetostnih električnih pulzov na membranske proteine pri elektroporaciji
Funder:
ARIS - Slovenian Research and Innovation Agency
Funding programme:
Young Researcher Program
Funder:
EC - European Commission
Project number:
893077
Name:
Controlling the susceptibility of biological cells to pulsed electric field treatment by using ion channel modulators
Acronym:
EPmIC
Funder:
ARIS - Slovenian Research and Innovation Agency
Name:
Electrical excitability of biological cells and tissues in silico (start-up research programme)
Funder:
Other - Other funder or multiple funders
Funding programme:
Medtronic
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
MN-0023-2024
Name:
Controlling thesusceptibility of biologicalcells to pulsed electric fieldtreatment by using ionchannel modulators
Funder:
EC - European Commission
Project number:
101115323
Name:
Reversible and irreversible cardiac electroporation: Establishing the fundamentals to advance cardiac treatments
Acronym:
REINCARNATION
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back